Cysteine Hydrochloride → Methyl 2-(2,5-dihydroxyphenyl)-1,3-thiazolidine-4-carboxylate

HRID 276977

Reaktionsgleichung

Reaktionsgleichung von HRID 276977
C([C:3]1([C:11]2[CH:16]=[C:15]([OH:17])[CH:14]=[CH:13][C:12]=2[OH:18])[NH:7][CH:6]([C:8]([O-:10])=[O:9])[CH2:5][S:4]1)C.Cl.N[C@H:21](C(O)=O)CS>>[OH:18][C:12]1[CH:13]=[CH:14][C:15]([OH:17])=[CH:16][C:11]=1[CH:3]1[NH:7][CH:6]([C:8]([O:10][CH3:21])=[O:9])[CH2:5][S:4]1

Komponenten

3

Edukt 2

HCID 60960Cysteine HydrochlorideHCID 86587248Ethyl-(2,5-dihydroxyphenyl)-1,3-thiazolidine-4-carboxylate

Produkt 1

HCID 9837958Methyl 2-(2,5-dihydroxyphenyl)-1,3-thiazolidine-4-carboxylate

Versuchsvorschrift

The procedure described below for preparation of ethyl-(2,5-dihydroxyphenyl)-1,3-thiazolidine-4-carboxylate (7) was employed to make 6, except the methyl ester of L-cysteine hydrochloride was employed as starting material.

Quellen und Nachweise

ORD-Eintrag
ord-f37da166f1014f5c9371b02ae8ec0e7f
Quelldatensatz
uspto-grants-2002_03
Patentnummer
US06355661B1

Verknüpfte Notizen

Wird geladen…